Bausch Health announces Q3 2025 results; exhibit with details not provided

Bausch Health Companies Inc.

2025-Q3 EPS reported $0.72 revenue$7,470,000,000

Press release for Q3 ended September 30, 2025 issued on October 29, 2025.
No specific financial figures (revenue, EPS, segments) are included in the filing body.
Exhibit 99.1 referenced but not appended; results are unknown to the analyst.
Common shares trade under ticker BHC on NYSE and Toronto Stock Exchange.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.